Rylo Health review
The headline is $99.67 a month, which is a quarterly bill divided by three — the exact arithmetic that makes another seller on this page misleading. What makes Rylo different is what it does next to that figure: it prints "$299 every 3 months · $139 monthly" on the same line, states under the block that the price reflects the quarterly rate, and then shows its flat pricing rather than claiming it — 2.5 mg, 5.0 mg and 7.5 mg, all at $229.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Rylo Health at a glance
- Semaglutide
- $139/mo month to month
- Tirzepatide
- $229/mo month to month
- Coverage
- Not published; described only as licensed US providers
- Brand-name
- Compounded only
How we scored Rylo Health
Each score comes out of Rylo Health's published pricing, disclosures and oversight, and the six combine into the 57/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The headline rate obscures a plan requirement or a hidden step-up.
Cost is unpredictable, premium, or hides behind a plan commitment.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- rylohealth.com
Verified 18 August 2026. Month to month, compounded semaglutide is $139 and tirzepatide $229. The quarterly plans are $299 and $479, which is $99.67 and $159.67 a month — and those are the figures the site leads with, the same arithmetic that makes another entry on this page misleading. Three things separate it. The month-to-month price is printed on the same line as the quarterly one. The site states under the pricing block that the figure reflects a quarterly rate billed every three months. And every division on the page recomputes exactly. It also demonstrates its flat pricing instead of asserting it, showing 2.5 mg, 5.0 mg and 7.5 mg all at $229. There is no membership fee, shipping is free every month, HSA and FSA are accepted and cancellation is stated as available at any time. Two cautions: non-GLP-1 treatments are priced in the same grid in the same format, and no compounding pharmacy, state list or operating address is published. Rylo Health LLC appears in both its Terms and its privacy policy and screened clean against the live FDA warning-letter index.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $139 | Month to month, flat at every dose"$299 every 3 months · $139 monthly", printed on the same line as the quarterly-derived "$99.67 /mo". Flat across the dose ladder and no membership fee. |
| Compounded tirzepatide | $229 | Month to month, flat at every dose"$479 every 3 months · $229 monthly". The site demonstrates the flat price rather than asserting it: "Month 1 2.5 mg $229 / Month 2 5.0 mg $229 / Month 3 7.5 mg $229". |
| Compounded semaglutide | $99.67 | Quarterly plan$299 billed every three months. The site states "Pricing reflects the quarterly rate, billed every 3 months" under the block rather than leaving it to be worked out. |
| Compounded tirzepatide | $159.67 | Quarterly plan$479 billed every three months. Every quarterly division on this page is exact. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Rylo Health's public disclosures at last review and change often; confirm the current number on Rylo Health's own site.
What we like
- Prints the monthly price beside the quarterly one, so nobody has to do the division
- Says explicitly that the headline reflects a quarterly rate — the sentence most sellers with this structure leave out
- Shows the flat price across three ascending doses instead of asserting it
- No membership fee, free monthly shipping, HSA and FSA accepted, cancel any time
- Every quarterly division on the page checks out exactly
- Same-day provider review, with the dose compounded to the prescription
The caveats
- The figure it leads with is still the quarterly-derived one; a skim reads $99.67, not $139
- NAD+, sermorelin and glutathione are priced in the same grid, in the same format, and are not GLP-1s
- "Our compounding pharmacy" is as specific as it gets
- No state list — "licensed US providers" is the whole coverage claim
- Several products sit under "coming soon", so the range is still moving
- No operating address anywhere
Rylo Health for mothers: our verdict
The headline is $99.67 a month, which is a quarterly bill divided by three — the exact arithmetic that makes another seller on this page misleading. What makes Rylo different is what it does next to that figure: it prints "$299 every 3 months · $139 monthly" on the same line, states under the block that the price reflects the quarterly rate, and then shows its flat pricing rather than claiming it — 2.5 mg, 5.0 mg and 7.5 mg, all at $229. It runs about $139/month — toward the affordable end of what we track.
We weigh Rylo Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Rylo Health actually costs
- Compounded semaglutide — Month to month, flat at every dose: $139/mo
- Compounded tirzepatide — Month to month, flat at every dose: $229/mo
- Compounded semaglutide — Quarterly plan: $99.67/mo
- Compounded tirzepatide — Quarterly plan: $159.67/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Rylo Health prescribes
Rylo Health prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Rylo Health fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Rylo Health's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Rylo Health is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who expects her dose to climb and wants the monthly number to stay put when it does.
Alternatives to Rylo Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Rylo Health
Head-to-head & alternatives
Rylo Health, answered
- How much does Rylo Health cost?
- When we last checked, the cheapest ongoing compounded price at Rylo Health was around $139 a month: $139/mo month to month for semaglutide and $229/mo month to month for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is Rylo Health safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Rylo Health as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does Rylo Health offer both semaglutide and tirzepatide?
- Yes — Rylo Health offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Rylo Health rank for mothers?
- Rylo Health takes 57/100 in our Editors' Rating, placing it #126. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect Rylo Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.